Hostname: page-component-7b7567c8c-tnkh4 Total loading time: 0 Render date: 2026-11-16T12:21:00.563Z Has data issue: false hasContentIssue false

Quality of economic evaluations of drug-coated balloons and drug-eluting stents in peripheral artery disease: a systematic review

Published online by Cambridge University Press:  06 August 2021

Aurélie Etangsale
Affiliation:
Pharmacy Department, Georges Pompidou European Hospital, AP-HP, 20 Rue Leblanc, 75015 Paris, France
Leonarda Nunno
Affiliation:
Pharmacy Department, Georges Pompidou European Hospital, AP-HP, 20 Rue Leblanc, 75015 Paris, France
Judith Pineau
Affiliation:
Pharmacy Department, Georges Pompidou European Hospital, AP-HP, 20 Rue Leblanc, 75015 Paris, France
Patrice Prognon
Affiliation:
Pharmacy Department, Georges Pompidou European Hospital, AP-HP, 20 Rue Leblanc, 75015 Paris, France
Nicolas Martelli*
Affiliation:
Pharmacy Department, Georges Pompidou European Hospital, AP-HP, 20 Rue Leblanc, 75015 Paris, FranceUniversité Paris-Saclay GRADES, 92290 Châtenay-Malabry, France
*
Author for correspondence: Nicolas Martelli, E-mail: nicolas.martelli@aphp.fr
Rights & Permissions [Opens in a new window]

Abstract

Objective

We aimed to perform a systematic review of economic evaluations of drug-coated balloons (DCBs) and drug-eluting stents (DESs) in peripheral artery disease (PAD) and to assess the level of evidence of relevant studies. The purpose was not to present economic findings.

Methods

A systematic review was performed using four electronic databases to identify health economic evaluation studies reporting on the use of DCBs and DESs in PAD. The methodological and reporting quality of the studies was assessed using three different tools, the Drummond, Cooper, and CHEERS (Consolidated Health Economic Evaluation Reporting Standards) checklists.

Results

Six articles were included in this review of the 1,728 publications identified. Four studies were cost-effectiveness analyses and two cost–utility analyses. According to the Cooper hierarchy scale, the studies used good-quality data sources. The level of evidence used for clinical effect sizes, safety data, baseline clinical data, and costs was of high quality in general. In contrast, an evaluation of the reporting quality suggested that essential information was lacking.

Conclusion

The present study demonstrates that clinical data used in economic evaluations of DCBs and DESs in PAD are from clinical studies of high quality in general. However, the quality of reporting represents a concern when interpreting the results provided by these economic studies.

Information

Type
Assessment
Copyright
Copyright © The Author(s), 2021. Published by Cambridge University Press
Figure 0

Table 1.Study eligibility criteria in PICOS format

Figure 1

Figure 1.PRISMA flowchart for study selection. CEA, Cost-Effectiveness Analysis; DCB, drug-coated balloon; DES, drug-eluting stent; NHS EED, National Health Service Economic Evaluation Database.

Figure 2

Table 2.Details of the Drummond checklist criteria for each included study

Figure 3

Table 3.Summary of the main results of the Cooper and CHEERS checklists

Supplementary material: File

Etangsale et al. supplementary material

Etangsale et al. supplementary material 1

Download Etangsale et al. supplementary material(File)
File 13.4 KB
Supplementary material: File

Etangsale et al. supplementary material

Etangsale et al. supplementary material 2

Download Etangsale et al. supplementary material(File)
File 64.5 KB
Supplementary material: File

Etangsale et al. supplementary material

Etangsale et al. supplementary material 3

Download Etangsale et al. supplementary material(File)
File 23 KB